StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
14
Publishing Date
2021 - 03 - 22
13
2014 - 04 - 07
1
Sector
Health technology
13
Technology services
1
Tags
Acquisition
10
Alliances
3
Analytics
3
Application
3
Approval
6
Awards
4
Biopharma
3
Bioscience
10
Biotech
6
Biotech-beach
4
Cancer
7
China
3
Clinical-trials-phase-ii
3
Collaboration
7
Commercialization
3
Conference
26
Covid
8
Device
5
Disease
3
Distribution
6
Drug
9
Earnings
5
Energy
7
Events
11
Expansion
9
Fda
4
Fda approval
3
Financial results
18
Growth
4
Health
4
Injection
3
Iot
10
License
3
Life science
4
Liver
3
Market
4
Merge
4
Mergers-and-acquisitions
5
N/a
248
New drug
3
Oda
3
Offering
15
People
7
Pharma
3
Phase 1
5
Phase 2
7
Phase 3
5
Positive
4
Presentation
8
Product-news
8
Program
7
Research
10
Results
27
Technology
6
Test
5
Therapeutics
4
Therapy
4
Treatment
14
Trial
8
Vaccine
5
Entities
Acer therapeutics inc.
1
Aveo pharmaceuticals, inc.
1
Baxter international inc.
1
Compass pathways plc
1
Eli lilly and company
1
Fortress biotech, inc.
2
Glaxosmithkline plc
1
Johnson & johnson
2
La jolla pharmaceutical company
1
Nanthealth, inc.
1
Novo nordisk a/s
1
Pfizer, inc.
1
Redhill biopharma ltd.
1
Rocket pharmaceuticals, inc.
1
Sanofi
1
Tonix pharmaceuticals holding corp.
1
Viatris inc.
1
Xenetic biosciences, inc.
1
Zealand pharma a/s
1
Symbols
ACER
1
AVEO
1
BAX
1
CMPS
1
FBIO
2
GSK
1
JNJ
2
LJPC
1
LLY
1
NH
1
NVO
1
PFE
1
RCKT
1
RDHL
1
SNY
1
TNXP
1
VTRS
1
XBIO
1
ZEAL
1
Exchanges
Nasdaq
13
Nyse
4
Crawled Date
2024 - 03 - 19
12
2024 - 03 - 04
13
2023 - 12 - 12
13
2023 - 12 - 06
14
2023 - 11 - 27
12
2023 - 10 - 18
12
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
17
2023 - 09 - 20
12
2023 - 09 - 07
14
2023 - 08 - 23
12
2023 - 06 - 26
13
2023 - 04 - 25
13
2023 - 04 - 17
14
2023 - 02 - 23
12
2023 - 01 - 30
16
2023 - 01 - 25
14
2022 - 11 - 17
12
2022 - 10 - 12
13
2022 - 09 - 14
12
2022 - 08 - 22
13
2022 - 05 - 17
13
2022 - 03 - 28
14
2022 - 01 - 24
16
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
14
2021 - 11 - 12
11
2021 - 11 - 01
12
2021 - 10 - 25
11
2021 - 10 - 19
11
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
13
2021 - 10 - 04
12
2021 - 09 - 30
11
2021 - 09 - 09
11
2021 - 09 - 07
12
2021 - 08 - 24
11
2021 - 07 - 13
11
2021 - 06 - 29
12
2021 - 06 - 28
11
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
13
2021 - 04 - 30
11
2021 - 04 - 15
11
2021 - 03 - 22
14
2020 - 12 - 15
14
2020 - 12 - 03
11
2020 - 12 - 02
12
2020 - 12 - 01
18
Crawled Time
03:00
1
07:00
1
11:00
1
12:00
2
13:00
2
13:15
2
14:00
2
19:00
1
22:00
2
Source
investor.aveooncology.com
1
nanthealth.com
1
www.biospace.com
4
www.globenewswire.com
6
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Treatment
crawled date :
2021 - 03 - 22
save search
Novo Nordisk receives Refusal to File letter for once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Published:
2021-03-22
(Crawled : 22:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
73.75%
|
O:
-2.35%
H:
0.49%
C:
-2.0%
diabetes
treatment
Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with Diabetes
Published:
2021-03-22
(Crawled : 22:00)
- globenewswire.com
ZEAL
|
$17.59
1.21%
-4.21%
|
Health Technology
|
-49.45%
|
O:
-0.89%
H:
0.09%
C:
-4.87%
diabetes
treatment
fda
fda approval
injection
hypoglycemia
approval
pharma
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA on TNX-601 CR for the Treatment of Major Depressive Disorder
Published:
2021-03-22
(Crawled : 19:00)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-89.94%
|
O:
-3.36%
H:
0.69%
C:
-4.17%
treatment
fda
results
depression
major depressive disorder
Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular AcneAccutane is Journey Medical’s sixth marketed dermatology product
Published:
2021-03-22
(Crawled : 14:00)
- biospace.com/
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
-58.19%
|
O:
0.71%
H:
2.0%
C:
-1.42%
treatment
acne
biotech
license
iot
Onychomycosis Treatment Manufacturers Find Opportunities in Novel Therapeutic Offerings: FMI Report
Published:
2021-03-22
(Crawled : 14:00)
- biospace.com/
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
-24.76%
|
O:
0.88%
H:
0.17%
C:
-0.8%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.74%
|
O:
-1.08%
H:
1.48%
C:
1.38%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
9.06%
|
O:
-0.79%
H:
1.1%
C:
0.91%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.11%
|
O:
-1.64%
H:
1.2%
C:
0.39%
offering
treatment
Psychedelics Becoming Valuable Alternatives to Conventional Mental Health Treatments
Published:
2021-03-22
(Crawled : 13:15)
- prnewswire.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-27.69%
|
O:
-0.14%
H:
1.49%
C:
1.47%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.74%
|
O:
-1.08%
H:
1.48%
C:
1.38%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
305.2%
|
O:
-0.13%
H:
1.01%
C:
0.97%
CMPS
|
$8.53
-2.85%
-2.93%
320K
|
Health Technology
|
-77.63%
|
O:
-1.94%
H:
3.92%
C:
-0.13%
treatment
health
Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular Acne
Published:
2021-03-22
(Crawled : 13:15)
- globenewswire.com
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
-58.19%
|
O:
0.71%
H:
2.0%
C:
-1.42%
treatment
acne
biotech
license
iot
Patient-Centered Cancer Care: New Treatments and Defining Quality
Published:
2021-03-22
(Crawled : 13:00)
- nanthealth.com
NH
|
$1.35
-46.64%
-1.48%
0
|
Technology Services
|
-61.1%
|
O:
0.0%
H:
2.02%
C:
0.58%
treatment
cancer
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Published:
2021-03-22
(Crawled : 13:00)
- globenewswire.com
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-73.99%
|
O:
19.65%
H:
6.28%
C:
-5.8%
urea
urine
disease
treatment
commercialization
collaboration
license
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland
Published:
2021-03-22
(Crawled : 12:00)
- biospace.com/
RDHL
|
$0.3935
2.21%
2.16%
240K
|
Health Technology
|
-94.88%
|
O:
2.13%
H:
1.82%
C:
0.0%
covid
treatment
biopharma
switzerland
opaganib
covid-19
Rocket Pharmaceuticals Announces Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301 for the Treatment of Pyruvate Kinase Deficiency
Published:
2021-03-22
(Crawled : 12:00)
- biospace.com/
RCKT
M
|
$23.7
-2.27%
-2.32%
640K
|
Health Technology
|
-55.65%
|
O:
-0.64%
H:
7.12%
C:
1.8%
treatment
phase 1
positive
trial
phase 3
phase 2
AVEO Oncology Announces U.S. Commercial Availability of FOTIVDA® (tivozanib) for the Treatment of Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma Ahead of Previous Guidance
Published:
2021-03-22
(Crawled : 11:00)
- investor.aveooncology.com
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
44.04%
|
O:
5.67%
H:
0.0%
C:
-5.91%
treatment
renal
commercialization
cell carcinoma
Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis
Published:
2014-04-07
(Crawled : 07:00)
- globenewswire.com
BAX
|
News
|
$39.52
-0.13%
0.0%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
XBIO
|
$4.015
-4.09%
2.8K
|
Health Technology
|
Email alert
Add to watchlist
treatment
fibrosis
phase 1
positive
phase 3
phase 2
cystic fibrosis
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava™ for the Treatment of Complicated Intra-abdominal Infections
Published:
2021-03-22
(Crawled : 03:00)
- prnewswire.com
LJPC
|
$6.22
0.0%
|
Health Technology
|
17.84%
|
O:
0.19%
H:
1.99%
C:
-3.6%
new drug
treatment
china
drug
injection
infections
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.